"...treating the cause rather than the symptom."
Ben Change, CEO
Our goal is to offer better care and first-line targeted therapies in the areas of hematology, oncology, neurology, and lung disorders.
About us
Advisory Board


Professor Renping Zhou
Dr. Zhou is an Associate Dean for Research at Rutgers University. Dr. Zhou received his PhD in Molecular Biology from the University of California, Berkeley, followed by postdoctoral training at the National Cancer Institute, where he focused on molecular signaling for cell growth and differentiation. Dr. Zhou was the recipient of many notable awards including the Johnson and Johnson Discovery award as well as the Trophix Pharmaceutical Research award. Over his career, Dr. Zhou has published 80+ peer reviewed papers on molecular mechanisms.


Professor Xi Zheng
Dr. Zheng is a Chemical Biology Research Professor at Rutgers University. Dr. Zheng received his PhD in Chemical Biology from the Karolinska Institute in Stockholm, Sweden. His career has been devoted on the study on mechanisms of anti-inflammatory and anti-cancer effect of naturally occurring compounds as well as the development of effective combinations of nutritional and natural agents for prevention of chronic diseases. Over his career, Dr. Zheng has published 17 publications.


Xiaoxin Luke Chen
Dr. Chen is a professor at Coriell Institute for Medical Research. Dr. Chen received his PhD in Biochemistry followed by his postdoctoral training at Rutgers University. Prior to Coriell, Dr. Chen was a professor of biological and biomedical science at North Carolina Central University’s (NCCU) Biomedical Biotechnology Research Institute where he investigated molecular mechanisms and targeted therapy of esophageal cancers. Since 2002, Dr. Chen has been continuously supported by NIH grants to investigate treatment options for esophageal diseases. Throughout his career, Dr. Chen has published 120+ publications.